Skip to main content
. 2010 Aug 31;25(3):294–300. doi: 10.3904/kjim.2010.25.3.294

Table 3.

Analysis of the progression-free survival according to clinical factors

graphic file with name kjim-25-294-i003.jpg

EGFR TKI, epidermal growth factor receptor tyrosine kinase inhibitor; ECOG, Eastern Cooperative Oncology Group; PD, progressive disease.